Myocardial protection with phosphocreatine in high-risk cardiac surgery patients: a randomized trial

BACKGROUND: This study was conducted to test the hypothesis that phosphocreatine (PCr), administered intravenously and as cardioplegia adjuvant in patients undergoing cardiac surgery with prolonged aortic cross clamping and cardiopulmonary bypass (CPB) time, would decrease troponin I concentration a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lomivorotov, Vladimir, Merekin, Dmitry, Fominskiy, Evgeny, Ponomarev, Dmitry, Bogachev-Prokophiev, Alexander, Zalesov, Anton, Cherniavsky, Alexander, Shilova, Anna, Guvakov, Dmitry, Lomivorotova, Liudmila, Lembo, Rosalba, Landoni, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685505/
https://www.ncbi.nlm.nih.gov/pubmed/38030971
http://dx.doi.org/10.1186/s12871-023-02341-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685505/
https://www.ncbi.nlm.nih.gov/pubmed/38030971
http://dx.doi.org/10.1186/s12871-023-02341-4

Ejemplares similares